Is meta-analysis the platinum standard of evidence?

Studies in History and Philosophy of Science Part C :Studies in History and Philosophy of Biological and Biomedical Sciences

Volumn 42, Issue 4, 2011, Pages 497-507

  Stegenga, Jacob ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Epidemiology; Evidence; Medicine; Meta analysis; Randomized controlled trial (RCT); Sir Bradford Hill

Indexed keywords

ARTICLE; DECISION MAKING; EVIDENCE BASED PRACTICE; HUMAN; MEDICAL RESEARCH; META ANALYSIS (TOPIC); METHODOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESEARCH; SOCIOLOGY; STANDARD;

BIOMEDICAL RESEARCH; DECISION MAKING; EVIDENCE-BASED PRACTICE; HUMANS; META-ANALYSIS AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH; SOCIOLOGY;

EID: 82555197914     PISSN: 13698486     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.shpsc.2011.07.003     Document Type: Article

References (73)

1. Assendelft W.J., Koes B.W., Knipschild P.G., Bouter L.M. The relationship between methodological quality and conclusions in reviews of spinal manipulation. The Journal of the American Medical Association 1995, 274:1942-1948.
2. Bachand A.M., Mundt K.A., Mundt D.J., Montgomery R.R. Epidemiological studies of formaldehyde exposure and risk of leukemia and nasopharyngeal cancer: A meta-analysis. Critical Reviews in Toxicology 2010, 40(2):85-100.
3. Banerjee, A., & Duflo, E. (Unpublished manuscript). The experimental approach to development economics. MIT JPAL manuscript. (accessed on 15.03.2011). http://www.povertyactionlab.org/methodology.
4. Barnes D., Bero L. Why review articles on the health effects of passive smoking reach different conclusions. The Journal of the American Medical Association 1998, 279(19):1566-1570.
5. Borenstein M., Hedges L.V., Higgins J.P.T., Rothstein H.R. Introduction to meta-analysis 2009, John Wiley and Sons, Chichester.
6. Borgenson, K. (2008). Valuing and evaluating evidence in medicine. PhD diss., University of Toronto.
7. Bosetti C., McLaughlin J.K., Tarone R.E., Pira E., La Vecchia C. Formaldehyde and cancer risk: A quantitative review of cohort studies through 2006. Annals of Oncology 2008, 19:29-43.
8. Broadbent A. Causation and models of disease in epidemiology. Studies in History and Philosophy of Biological and Biomedical Sciences 2009, 40:302-311.
9. Brown J. The community of science. The challenge of the social and the pressure of practice: Science and values revisited 2008, University of Pittsburgh Press, Pittsburgh. Carrier, Howard, Kourany (Eds.).
10. Cartwright N. Are RCTs the gold standard?. Biosocieties 2007, 2:11-20.
11. Cartwright, N. (2010). The long road from 'it works somewhere' to 'it will work for us'. Philosophy of Science Association, Presidential Address.
12. Cartwright N., Stegenga J. A theory of evidence for evidence-based policy. Evidence, inference and enquiry 2011, Oxford University Press. Dawid, Twining, Vasilaki (Eds.).
13. Charlton B.G. Attribution of causation in epidemiology: Chain or mosaic?. Journal of Clinical Epidemiology 1996, 49:105-107.
14. Cochrane Handbook. (available online). http://www.cochrane.org/resources/handbook.
15. Collins J.J., Lineker G.A. A review and meta-analysis of formaldehyde exposure and leukemia. Regulatory Toxicology and Pharmacology 2004, 40:81-91.
16. Danks D. Scientific coherence and the fusion of experimental results. The British Journal for the Philosophy of Science 2005, 56:791-807.
17. Daston L., Galison P. Objectivity 2007, Zone Books, Cambridge.
18. De Vreese L. Causal (mis)understanding and the search for scientific explanations: A case study from the history of medicine. Studies in History and Philosophy of Biological and Biomedical Sciences 2008, 39:14-24.
19. Deaton A. Instruments of development: Randomisation in the tropics, and the search for the elusive keys to economic development. Proceedings of the British Academy 2008, 162:123-160.
20. Doll R. Fisher and Bradford Hill: Their personal impact. International Journal of Epidemiology 2003, 32:929-931.
21. Doll R., Hill A.B. Smoking and carcinoma of the lung: Preliminary report. British Medical Journal 1950, 2(4682):739-748.
22. Doll R., Hill A.B. The mortality of doctors in relation to their smoking habits. British Medical Journal 1954, 1(4877):1451-1455.
23. Douglas H. The irreducible complexity of objectivity. Synthese 2004, 138(3):453-473.
24. Duflo, E., & Kremer, M. (2003). The use of randomization in the evaluation of development effectiveness. World Bank manuscript. (accessed on 15.03.2011). http://www.povertyactionlab.org/methodology.
25. Egger M., Smith G.D., Phillips A.N. Meta-analysis: Principles and procedures. British Medical Journal 1997, 315:1533-1537.
26. Epstein S. Inclusion: The politics of difference in medical research 2007, Chicago University Press, Chicago.
27. Eysenck H. Meta-analysis: An abuse of research integration. Journal of Special Education 1984, 18(1):41-59.
28. Eysenck H. Systematic reviews: Meta-analysis and its problems. British Medical Journal 1994, 309:789-792.
29. Fergusson D., Doucette S., Glass K.C., Shapiro S., Healy D., Hebert P., et al. Association between suicide attempts and selective serotonin reuptake inhibitors: Systematic review of randomised controlled trials. British Medical Journal 2005, 330:396-399.
30. Glass G.V. Primary, secondary and meta-analysis of research. Educational Researcher 1976, 10:3-8.
31. Glass G.V., Smith M.L. Meta-analysis of research on class size and achievement. Educational Evaluation and Policy Analysis 1979, 1(1):2-16.
32. Gunnell D., Saperia J., Ashby D. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: Meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review. British Medical Journal 2005, 330:385-388.
33. Hacking I. Telepathy: Origins of randomization in experimental design. Isis 1988, 79(3):427-451.
34. Hartling L., Ospina M., Liang Y., Dryden D., Hooten N., Seida J., et al. Risk of bias versus quality assessment of randomised controlled trials: Cross sectional study. British Medical Journal 2009, 339:b4012.
35. Hill B. The environment and disease: Association or causation?. Proceedings of the Royal Society of Medicine 1965, 58:295-300.
36. Hodge D.R. A systematic review of the empirical literature on intercessory prayer. Research on Social Work Practice 2007, 17:174-187.
37. Howick J., Glasziou P., Aronson J.K. The evolution of evidence hierarchies: What can Bradford Hill's 'guidelines for causation' contribute?. Journal of the Royal Society of Medicine 2009, 102:186-194.
38. Jaber B.L., Lau J., Schmid C.H., Karsou S.A., Levey A.S., Pereira B.J. Effect of biocompatibility of hemodialysis membranes on mortality in acute renal failure: A meta-analysis. Clinical Nephrology 2002, 57(4):274-282.
39. Jüni P., Witschi A., Bloch R., Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. The Journal of the American Medical Association 1999, 282(11):1054-1060.
40. Klein R., Williams A. Setting priorities: what is holding us back-inadequate information or inadequate institutions?. The global challenge of health care rationing 2000, Open University Press. Coulter, Ham (Eds.).
41. Knipschild P. Systematic reviews: Some examples. British Medical Journal 1994, 309:719-721.
42. Kunda Z. The case for motivated reasoning. Psychological Bulletin 1990, 108(3):480-498.
43. Linde K., Willich S. How objective are systematic reviews? Differences between reviews on complementary medicine. Journal of the Royal Society of Medicine 2003, 96:17-22.
44. Lomas J., Fulop N., Gagnon D., Allen P. On being a good listener: Setting priorities for applied health services research. Milbank Quarterly 2003, 81(3):363-388.
45. Masters K.S., Spielmans G.I. Prayer and health: Review, meta-analysis, and research agenda. Journal of Behavioral Medicine 2007, 30(4):329-338.
46. McAuley L., Pham B., Tugwell P., Moher D. Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses?. Lancet 2000, 356(9237):1228-1231.
47. Miller, B. (2010). A social theory of knowledge. PhD diss., University of Toronto.
48. Mnookin, J. (2008). Under the influence of technology: DUI and the legal production of objectivity. UCSD Science Studies Colloquium (21.04.2008).
49. Moher D., Cook D.J., Eastwood S., Olkin I., Rennie D., Stroup D., et al. Improving the quality of reports of meta-analyses of randomised controlled trials: The QUORUM statement. Lancet 1999, 354:1896-1900.
50. Moher D., Jadad A.R., Nichol G., Penman M., Tugwell P., Walsh S. Assessing the quality of randomized controlled trials: An annotated bibliography of scales and checklists. Controlled Clinical Trials 1995, 16:62-73.
51. Pauling L. How to live longer and feel better 1986, W.H. Freeman, New York.
52. Rhine J.B., Pratt J.G., Stuart C.E., Smith B.M., Greenwood J.A. Extrasensory perception after sixty years 1940, Holt, New York.
53. Roberts L., Ahmed I., Hall S., Davison A. Intercessory prayer for the alleviation of ill health. Cochrane Database of Systematic Reviews 2009, 15(2):CD000368.
54. Rothman K.J., Greenland S. Causation and causal inference in epidemiology. American Journal of Public Health 2005, 95:S144-S150.
55. Rotton J., Kelly I.W. Much ado about the full moon: A meta-analysis of lunar-lunacy research. Psychological Bulletin 1985, 97:286-306.
56. Slavin R. Best evidence synthesis: An intelligent alternative to meta-analysis. Journal of Clinical Epidemiology 1995, 48(1):9-18.
57. Smith M.L., Glass G.V. Meta-analysis of psychotherapy outcome studies. American Psychologist 1977, 32:752-760.
58. Smith G.C., Pell J.P. Parachute use to prevent death and major trauma related to gravitational challenge: Systematic review of randomised controlled trials. British Medical Journal 2003, 327(7429):1459-1461.
59. Stegenga J. Robustness, discordance, and relevance. Philosophy of Science 2009, 76:650-661.
60. Subramanian S., Venkataraman R., Kellum J.A. Influence of dialysis membranes on outcomes in acute renal failure: A meta-analysis. Kidney International 2002, 62:1819-1823.
61. Sutton A.J., Higgins J.P.T. Recent developments in meta-analysis. Statistics in Medicine 2008, 27:625-650.
62. Thagard P. Ulcers and bacteria I: Discovery and acceptance. Studies in History and Philosophy of Biological and Biomedical Sciences 1998, 29:107-136.
63. Tricco A.C., Tetzlaff J., Pham B., Brehaut J., Moher D. Non-Cochrane vs. Cochrane reviews were twice as likely to have positive conclusion statements: Cross-sectional study. Journal of Clinical Epidemiology 2009, 62(4):380-386.
64. Trout J.D. Diverse tests on an independent world. Studies in History and Philosophy of Science 1995, 26(3):407-429.
65. Weed D. On the use of causal criteria. International Journal of Epidemiology 1997, 26:1137-1141.
66. Whitlock M., Schluter D. The analysis of biological data 2009, Roberts and Company Publishers, Greenwood Village.
67. Whittington C.J., Kendall T., Fonagy P., Cottrell D., Cotgrove A., Boddington E. Selective serotonin reuptake inhibitors in childhood depression: Systematic review of published versus unpublished data. Lancet 2004, 363(9418):1341-1345.
68. Wimsatt W. Robustness, reliability, and overdetermination. Scientific inquiry and the social sciences 1981, Jossey-Bass, San Francisco. Brewer, Collins (Eds.).
69. Woodward J. Causation in biology: Stability, specificity, and the choice of levels of explanation. Biology and Philosophy 2010, 25:287-318.
70. Worrall J. What evidence in evidence-based medicine?. Philosophy of Science 2002, 69:S316-S330.
71. Worrall J. Why there's no cause to randomize. The British Journal for the Philosophy of Science 2007, 58:451-488.
72. Yank V., Rennie D., Bero L.A. Financial ties and concordance between results and conclusions in meta-analyses: A retrospective cohort study. British Medical Journal 2007, 335:1202-1205.
73. Zhang L., Steinmaus C., Eastmond D.A., Xin X.K., Smith M.T. Formaldehyde exposure and leukemia: A new meta-analysis and potential mechanisms. Mutation Research 2009, 681:150-168.